BHOPAL: India develops first home-grown H5N1 bird flu vaccine for chickens. Union Minister Agriculture Farmers Welfare Rural Development Shri Shivraj Singh Chouhan will dedicate India's first indigenous Inactivated H5N1 (Clade 2.3.2.1a) Highly Pathogenic Avian Influenza (HPAI) Vaccine for Chickens to Nation Nov 20 2026 at ICAR-National Institute High Security Animal Diseases (ICAR-NIHSAD) Bhopal. Developed indigenously ICAR-NIHSAD Bhopal vaccine first kind India against H5N1 HPAI virus Clade 2.3.2.1a.
What is it:
Inactivated H5N1 (Clade 2.3.2.1a) HPAI Vaccine for Chickens.
Highly pathogenic avian influenza HPAI commonly bird flu serious disease affecting chickens other birds.
At present no specific commercial vaccine available against H5N1 virus Clade 2.3.2.1a.
Vaccine developed ICAR-NIHSAD aims address need providing protection against Clade 2.3.2.1a H5N1 virus strains circulating country.
Clade 2.3.2.1a identified responsible most bird flu outbreaks chickens country.
Why needed now:
Announcement comes time bird flu outbreaks once again reported different parts country resulting large-scale bird deaths containment measures.
India poultry industry — 3rd largest egg producer world, 4th largest chicken meat, ~ Rs 1.5 lakh crore, 30+ million livelihoods. Outbreak = culling lakhs birds, egg / chicken price crash, farmer ruin, export ban.
2025-26 outbreaks: Andhra Pradesh, Maharashtra, Odisha, West Bengal, Kerala, Jharkhand — ducks, chickens, crows. Nov 2026: Odisha, West Bengal culling.
Current India policy: cull, no vaccination — because vaccinated birds mask virus, trade partners ban. Vaccine changes strategy: prevention vs culling only.
Global H5N1 2.3.4.4b spreading mammals cattle cats humans US — pandemic fear. India clade 2.3.2.1a different, local.
How vaccine works:
Inactivated = killed virus — cannot cause disease, safe. Stimulates antibodies chickens. Protects against disease death, reduces shedding transmission.
Developed NIHSAD BSL-3+ lab Bhopal — India's only high security animal disease lab, handles H5N1, African swine fever, lumpy skin.
Trials: lab challenge, field? PIB says developed, validated — efficacy safety data submitted CDSCO / DAHD.
What minister did NOT say:
Minister has not specified vaccine commercial availability production arrangements pricing vaccination schedule scale timeline deployment poultry farms.
Announcement does not itself establish when vaccine become commercially available how deployed poultry farms what vaccination protocols followed.
Need: technology transfer private vaccine makers — Hester, Indian Immunologicals, Venkateshwara Hatcheries — production scale, cold chain, dose cost Rs 5-15?, 2 doses?
Policy decision: DAHD + ICAR decide vaccination zones — ring vaccination around outbreaks, breeder / layer farms, not blanket? OIE / WOAH rules: vaccinated poultry can trade if DIVA strategy — Differentiate Infected from Vaccinated Animals.
What next:
- Dedication Nov 20 Bhopal — not rollout day.
- DAHD to frame HPAI vaccination policy, SOP.
- State animal husbandry depts identify high-risk districts — wetlands migratory birds, live markets.
- Farmers: continue biosecurity — foot baths, nets, no wild bird contact, report sudden deaths 100+ birds to vet, don't sell sick birds, don't eat dead birds.
For public:
H5N1 chicken vaccine NOT human vaccine. Eating cooked chicken egg safe — virus killed 70°C. Human cases India rare — 2024 West Bengal child recovered. Risk farm workers, cullers — PPE.
No need panic buy chicken — vaccine protects flock, stabilises supply price.
*Significance:*
Atmanirbhar animal vaccines — earlier ICAR developed lumpy skin vaccine Lumpi-ProVac, African swine fever vaccine in trials, FMD vaccine.
Indigenous = no import dependency, strain matched Indian clade — imported vaccines 2.3.4.4b / old H5N2 mismatch, poor protection.
One Health: animal vaccine = human pandemic prevention. Vaccinate chickens = less virus circulating = less spillover humans.
#H5N1 #BirdFlu #Vaccine #ICAR #NIHSAD #Poultry #ShivrajSinghChouhan #Bhopal #HPAI #Chicken